{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:39:56Z","timestamp":1761863996129,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.clcc.2019.07.008","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T11:52:34Z","timestamp":1564401154000},"page":"310-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety Report of TAS-102 in a Patient With Reduced DPD Activity"],"prefix":"10.1016","volume":"18","author":[{"given":"Elena","family":"Bolzacchini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Luchena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clcc.2019.07.008_bib1","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1200\/JCO.1998.16.11.3537","article-title":"Toxicity of fluorouracil in patients with advanced colorectal cancer: effect of administration schedule and prognostic factors","volume":"16","author":"L\u00e9vy","year":"1998","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clcc.2019.07.008_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2125.1998.00751.x","article-title":"Dihydropyrimidine dehydrogenase pharmacogenetics in Caucasian subjects","volume":"46","author":"Ridge","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.clcc.2019.07.008_bib3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","article-title":"Randomized trial of TAS-102 for refractory metastatic colorectal cancer","volume":"372","author":"Mayer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clcc.2019.07.008_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/1758834015603313","article-title":"Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies","volume":"7","author":"Peters","year":"2015","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.clcc.2019.07.008_bib5","first-page":"2832","article-title":"Prevalence of a common point mutation in the dihydropyrimidine dehydrogenase (DPD) gene within the 5'-splice donor site of intron 14 in patients with severe 5-fluorouracil (5-FU)- related toxicity compared with controls","volume":"7","author":"Raida","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clcc.2019.07.008_bib6","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cpt.685","article-title":"Quantitative contribution of rs75017182 to dihydropyrimidine dehydrogenase mRNA splicing and enzyme activity","volume":"102","author":"Nie","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clcc.2019.07.008_bib7","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S1470-2045(18)30686-7","article-title":"DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis","volume":"19","author":"Henricks","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clcc.2019.07.008_bib8","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/bjc.2017.289","article-title":"Dihydropyrimidine dehydrogenase pharmacogenetics for predicting fluoropyrimidine-related toxicity in the randomised, phase III adjuvant TOSCA trial in high-risk colon cancer patients","volume":"117","author":"Ruzzo","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clcc.2019.07.008_bib9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejca.2015.11.008","article-title":"Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: ready for prime time","volume":"54","author":"Lunenburg","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clcc.2019.07.008_bib10","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2019.07.008_bib11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s12885-016-2409-8","article-title":"TAS-102, the first \u201ccardio-gentle\u201d fluoropyrimidine in the colorectal cancer landscape?","volume":"16","author":"Petrelli","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clcc.2019.07.008_bib12","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0006-2952(00)00253-7","article-title":"Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'- deoxyribonucleosides","volume":"59","author":"Fukushima","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.clcc.2019.07.008_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1011178111295","article-title":"Safe administration of irinotecan, oxaliplatin and raltitrexed in a DPD-deficient patient with metastatic colon cancer","volume":"12","author":"Volk","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clcc.2019.07.008_bib14","first-page":"325","article-title":"Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer","volume":"17","author":"Salgado","year":"2007","journal-title":"Oncol Rep"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002819301823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002819301823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:06:37Z","timestamp":1761519997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002819301823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1533002819301823"],"URL":"https:\/\/doi.org\/10.1016\/j.clcc.2019.07.008","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety Report of TAS-102 in a Patient With Reduced DPD Activity","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clcc.2019.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}